You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Case of Mycoplasma genitalium pelvic inflammatory disease with perihepatitis
  1. Janet M Towns1,2,
  2. Deborah A Williamson3,4,
  3. Catriona S Bradshaw1,2
  1. 1 Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia
  2. 2 Faculty of Medicine, Nursing and Health Sciences, Central Clinical School, Monash University, Clayton, Victoria, Australia
  3. 3 Microbiological Diagnostic Unit Public Health Laboratory, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia
  4. 4 Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia
  1. Correspondence to Dr Janet M Towns, Melbourne Sexual Health Centre, Carlton, VIC 3053, Australia; jtowns{at}mshc.org.au

https://doi.org/10.1136/sextrans-2021-055279

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We report a case of Mycoplasma genitalium-associated pelvic inflammatory disease (PID) with perihepatitis, masquerading as gonococcal PID with Fitz-Hugh-Curtis syndrome (FHCS).

    A woman in her 30s attended with intermenstrual bleeding, nausea, urinary frequency, dysuria, abdominal pain and fever/chills. She was taking oral cephalexin for an Escherichia coli urinary tract infection. Examination revealed vaginal discharge (pH 5.5), normal cervix, mild forniceal tenderness, moderately severe right upper quadrant tenderness with guarding and mild suprapubic tenderness. Gram-negative diplococci were seen on microscopy. Pregnancy testing was …

    View Full Text

    Footnotes

    • Handling editor Anna Maria Geretti

    • Twitter @drdebwilliamson

    • Contributors JMT and CSB conceived and cowrote the article. DAW provided microbiological advice. All authors have reviewed the manuscript and approved the final version.

    • Funding JMT is supported by a Monash University postdoctoral bridging grant. CSB is supported by an NHMRC leadership fellowship grant (1173361). DAW is supported by an NHMRC Investigator Grant (APP1174555).

    • Competing interests CSB has received GeneXpert modules and test kits from Cepheid. CSB is on the advisory boards of Nabriva and GSK. Melbourne Sexual Health Centre receives research funding from SpeeDx.

    • Provenance and peer review Not commissioned; internally peer reviewed.